Condition: Spinal Disease · Degenerative Disc Disease · Sponsor: Collagen Matrix
The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
This description comes directly from the study's public registry record.
Meenakshi Paliwal · 12014051477 · mpaliwal@collagenmatrix.com
Peggy Hansen · 201-405-1477 · phansen@collagenmatrix.com
Always discuss trial participation with your own doctor first.
| San Diego Neurosurgery | Encinitas, California, United States | Not Yet Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
| University Orthopaedic Associates, Division of OrthoNJ | Somerset, New Jersey, United States | Not Yet Recruiting |
| McKenzie-willamette Medical Center | Eugene, Oregon, United States | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04775537